NF2 and ependymoma: Patients with NF2 are known to be at increased risk for multiple central nervous system tumors, including vestibular schwannomas, meningiomas, and intramedullary tumors (eg, ependymomas), which is why they undergo routine MRI screening of the brain and spine.